# Efficacy and Safety of the Flow Diverter (Tonbridge) for Endovascular Treatment of Intracranial Aneurysms

Study · id `cardio:ct-nct04799964` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04799964](<https://clinicaltrials.gov/study/NCT04799964>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT04799964

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 187 participants.

## Technical summary

Registry record NCT04799964. Randomized; no masking; primary purpose treatment. Start 2021-08-12 (actual); primary completion 2023-09-22 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 187 participants (enrolled count; ClinicalTrials.gov record NCT04799964, source copy `cardio:ctgov-nct04799964-2024-09-19`, retrieved 2026-11-18)
- Started: 2021-08-12 (actual) (ClinicalTrials.gov record NCT04799964, source copy `cardio:ctgov-nct04799964-2024-09-19`, retrieved 2026-11-18)
- Primary completion: 2023-09-22 (actual) (ClinicalTrials.gov record NCT04799964, source copy `cardio:ctgov-nct04799964-2024-09-19`, retrieved 2026-11-18)
- Completion: 2023-09-22 (actual) (ClinicalTrials.gov record NCT04799964, source copy `cardio:ctgov-nct04799964-2024-09-19`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT04799964, source copy `cardio:ctgov-nct04799964-2024-09-19`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04799964-2024-09-19`, retrieved 2026-11-18)

## The registry's words

- Brief title: Efficacy and Safety of the Flow Diverter (Tonbridge) for Endovascular Treatment of Intracranial Aneurysms
- Condition: Intracranial Aneurysm
- Intervention (Device): Flow Diverter (Tonbridge)
- Intervention (Device): Tubridge (MicroPort)
- Lead sponsor: Ton-Bridge Medical Tech. Co., Ltd
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Brain aneurysm (intracranial aneurysm) (`cardio:intracranial-aneurysm`)
- Registry lists this organization as the lead sponsor: Ton-Bridge Medical Tech. Co., Ltd (`cardio:org-ton-bridge-medical-tech-co-ltd`)

## Provenance

Content hash: 06e4407f40054796144b8ab868f21b9383d9a8409e282e5895ff49d83fa42e17
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
